Triple
T5481700
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | COVID-19 vaccines |
E123479
|
entity |
| Predicate | regulatoryApproval |
P24602
|
FINISHED |
| Object |
Conditional Marketing Authorization by European Medicines Agency
Conditional Marketing Authorization by the European Medicines Agency is a fast-track regulatory pathway that allows earlier approval of medicines, such as COVID-19 vaccines, based on less comprehensive data than normally required, provided that the benefits outweigh the risks and additional data will be supplied post-approval.
|
E523137
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69bd4648883481909e9775d43300c5fa |
elicitation | completed |
| NER | batch_69bd924a2eb08190b759b23a6eab5e0a |
ner | completed |
| NED1 | batch_69bf48a2880c8190ad76cf8c3862aede |
ned_source_triple | completed |
| NED2 | batch_69bf4afb47a88190a66de6b6c7d5c241 |
ned_description | completed |
| NEDg | batch_69bf4a95375881909ba730ad108eee8b |
nedg | completed |
Created at: March 20, 2026, 2:09 p.m.